Skip to main content
. 2021 Sep 30;12(10):893. doi: 10.1038/s41419-021-04190-w

Fig. 1. CRISPR/Cas9-based genome-wide screen reveals cellular OXPHOS-dependence upon alisertib treatment.

Fig. 1

A Schematic for genetic knockout screening to identify synergistic targets of alisertib in MDA-MB-231 cells. B Plot showing the distribution of CRISPR beta scores (treatment vs pretreatment) for genes targeted by the sgRNA library. Blue dots are the top 3000 negative enrichment genes. OXPHOS associated genes are highlighted. C KEGG showing significant enrichment of the OXPHOS pathway in the top 3000 negative enrichment genes. D GSEA analysis showing significant enrichment of OXPHOS and mitochondria respiration in the gene set that are induced upon 6 h alisertib treatment. E Enrichment graph of GO_Oxidative phosphorylation (NES = 2.426, p = 0) and GO_Mitochondrial inner membrane (NES = 2.345, p = 0). See also Fig. S1.